AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-90
Results: 26-50/90
CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT
Authors: STALDER N SUDRE P OLMARI M OPRAVIL M GABRIEL V SANSONETTI A VONOVERBECK J HERBORT CP HIRSCHEL B BATTEGAY M BURGISSER P JEANNEROD L EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: N. Stalder et al., CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT, Clinical infectious diseases, 24(4), 1997, pp. 620-624
IMPACT OF PUVA THERAPY ON HIV VIREMIA - A PILOT-STUDY
Authors: PECHERE M YERLY S LEMONNIER E KRISCHER J PERRIN L SAURAT JH
Citation: M. Pechere et al., IMPACT OF PUVA THERAPY ON HIV VIREMIA - A PILOT-STUDY, Dermatology, 195(1), 1997, pp. 84-85
IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY
Authors: EGGER M HIRSCHEL B FRANCIOLI P SUDRE P WIRZ M FLEPP M RICKENBACH M MALINVERNI R VERNAZZA P BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W GROB P GRUNINGER U JEANNEROD L LEDERGERBER B LUTHY R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RUTSCHMANN O ZANETTI G
Citation: M. Egger et al., IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY, BMJ. British medical journal, 315(7117), 1997, pp. 1194-1199
EXPERIMENTAL STUDIES AND MODELING OF SORPTION AND DIFFUSION OF WATER AND ALCOHOLS IN CELLULOSE-ACETATE
Authors: PERRIN L NGUYEN QT SACCO D LOCHON P
Citation: L. Perrin et al., EXPERIMENTAL STUDIES AND MODELING OF SORPTION AND DIFFUSION OF WATER AND ALCOHOLS IN CELLULOSE-ACETATE, Polymer international, 42(1), 1997, pp. 9-16
INTRAHEPATIC HEPATITIS-C VIRUS-REPLICATION AFTER LIVER-TRANSPLANTATION
Authors: NEGRO F GIOSTRA E KRAWCZYNSKI K QUADRI R RUBBIABRANDT L MENTHA G COLUCCI G PERRIN L HADENGUE A
Citation: F. Negro et al., INTRAHEPATIC HEPATITIS-C VIRUS-REPLICATION AFTER LIVER-TRANSPLANTATION, Hepatology, 26(4), 1997, pp. 102-102
IGM ANTI-HEPATITIS-C VIRUS CORE ANTIBODY AS MARKER OF RECURRENT HEPATITIS-C AFTER LIVER-TRANSPLANTATION
Authors: NEGRO F GIOSTRA E RUBBIABRANDT L TROONEN H SEIUM Y MICHEL G MENTHA G COLUCCI G PERRIN L QUADRI R HADENGUE A
Citation: F. Negro et al., IGM ANTI-HEPATITIS-C VIRUS CORE ANTIBODY AS MARKER OF RECURRENT HEPATITIS-C AFTER LIVER-TRANSPLANTATION, Hepatology, 26(4), 1997, pp. 339-339
DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS
Authors: LOW N PFLUGER D EGGER M BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B JEANNEROD L LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: N. Low et al., DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS, AIDS, 11(9), 1997, pp. 1165-1171
CHEMOTHERAPY FOR AIDS-RELATED MALIGNANCIES DOES NOT INCREASE HIV VIREMIA
Authors: RUTSCHMANN OT PECHERE M KRISCHER J PERRIN L HIRSCHEL B
Citation: Ot. Rutschmann et al., CHEMOTHERAPY FOR AIDS-RELATED MALIGNANCIES DOES NOT INCREASE HIV VIREMIA, AIDS, 11(7), 1997, pp. 944-945
ADDING SAQUINAVIR TO STAVUDINE IN PATIENTS WITH ADVANCED HIV-1 INFECTION
Authors: RUTSCHMANN OT KAISER L PERRIN L FATHI M HIRSCHEL BJ
Citation: Ot. Rutschmann et al., ADDING SAQUINAVIR TO STAVUDINE IN PATIENTS WITH ADVANCED HIV-1 INFECTION, AIDS, 11(4), 1997, pp. 548-548
IMMUNOLOGICAL MARKERS IN HIV-INFECTED PREGNANT-WOMEN
Authors: NEWELL ML RUDIN C DUNN D PECKHAM C GIAQUINTO C RUGA E DEROSSI A TRUSCIA D GROSCHWORNER I SCHAFER A MOK J JOHNSTONE F JIMINEZ J DEALBA C OMENACATERES F GARCIARODRIGUEZ MC BATES I DEJOSE I HAWKINS F ZAPICO RM CANOSA CA GONZALEZMOLINA A BONET FA SCHERPBIER H BOER K BOHLIN AB LINDGREN S EHRNST A ANZEN B BELFRAGE E LEVY J ALIMENTI A BARLOW P FERRAZIN A DEMARIA A GOTTA C",MARITATI,"MUR A PUGES MTR COLL O FORTUNY C BOGUNA J CARO MC CANET Y PARDI G RAVIZZA M SEMPRINI E CASTAGNA C FIORE S GUERRA B DALLACASA P BIANCHI S BOVICELLI L PRATI E ZANELLI S DUSE M SORESINA A SCARAVELLI G STEGAGNO M DESANTIS M MUGGIASCA ML MARCHISIO P IASCI A SPINILLO A BUCCERI A GROSSI E RANCILIO L CAMLI C SCHNURIGER H WEISSER M KULLY C BERGER R SCHAAD UB DESLEX N PAVIC N BIZER J SCHNEGG M SCHWENDKE A ERB P TICHELLI A BIEDERMANN K LAUPER U ZURRER M KHAN G FIERZ W JOLLER HI IRION O BRUNELLI AP PERRIN L YERLI S SPOLETINI G CHAVE JP SCHREYER A ISENSCHMID M MATHEZIOIC F OTT C DRACK G KELLER K ETIENNETURCHI M SAURENMANN E HELLER S PALY T PASSWER D HEINZL S KNOTEK K SPIRA JC HOLLINGER B SCHNEIDER W SPRENG M DAHLER R STAMM H DELALOYE M SAURINA A FLEISCHMANN R FROHLICHER J GROB B PALY T LEUPPI R WENK B LIMMACHER F HUBER S BRASCHLER C CORNU P GERRETSEN G AFFENTRANGER P POORBEIK M KIND C
Citation: Ml. Newell et al., IMMUNOLOGICAL MARKERS IN HIV-INFECTED PREGNANT-WOMEN, AIDS, 11(15), 1997, pp. 1859-1865
TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR
Authors: LORENZI P YERLY S ABDERRAKIM K FATHI M RUTSCHMANN OT VONOVERBECK J LEDUC D PERRIN L HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: P. Lorenzi et al., TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR, AIDS, 11(12), 1997, pp. 95-99
HIGH-TITERED ANTI-HBS FRESH-FROZEN PLASMA FOR IMMUNOPROPHYLAXIS AGAINST HEPATITIS-B VIRUS RECURRENCE AFTER LIVER-TRANSPLANTATION
Authors: MENTHA G GIOSTRA E NEGRO F RUBBIABRANDT L HUBER O HADENGUE A PERRIN L MOREL P
Citation: G. Mentha et al., HIGH-TITERED ANTI-HBS FRESH-FROZEN PLASMA FOR IMMUNOPROPHYLAXIS AGAINST HEPATITIS-B VIRUS RECURRENCE AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 29(5), 1997, pp. 2369-2373
THE QUALITATIVE NATURE OF THE PRIMARY IMMUNE-RESPONSE TO HIV-INFECTION IS A PROGNOSTICATOR OF DISEASE PROGRESSION INDEPENDENT OF THE INITIAL LEVEL OF PLASMA VIREMIA
Authors: PANTALEO G DEMAREST JF SCHACKER T VACCAREZZA M COHEN OJ DAUCHER M GRAZIOSI C SCHNITTMAN SS QUINN TC SHAW GM PERRIN L TAMBUSSI G LAZZARIN A SEKALY RP SOUDEYNS H COREY L FAUCI AS
Citation: G. Pantaleo et al., THE QUALITATIVE NATURE OF THE PRIMARY IMMUNE-RESPONSE TO HIV-INFECTION IS A PROGNOSTICATOR OF DISEASE PROGRESSION INDEPENDENT OF THE INITIAL LEVEL OF PLASMA VIREMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(1), 1997, pp. 254-258
GENETIC-POLYMORPHISM OF CCR5 GENE AND HIV DISEASE - THE HETEROZYGOUS (CCR5 DELTA-CCR5) GENOTYPE IS NEITHER ESSENTIAL NOR SUFFICIENT FOR PROTECTION AGAINST DISEASE PROGRESSION/
Authors: MORAWETZ RA RIZZARDI GP GLAUSER D RUTSCHMANN O HIRSCHEL B PERRIN L OPRAVIL M FLEPP M VONOVERBECK J GLAUSER MP GHEZZI S VICENZI E POLI G LAZZARIN A PANTALEO G
Citation: Ra. Morawetz et al., GENETIC-POLYMORPHISM OF CCR5 GENE AND HIV DISEASE - THE HETEROZYGOUS (CCR5 DELTA-CCR5) GENOTYPE IS NEITHER ESSENTIAL NOR SUFFICIENT FOR PROTECTION AGAINST DISEASE PROGRESSION/, European Journal of Immunology, 27(12), 1997, pp. 3223-3227
SAFER SEX BEHAVIOR AND ALCOHOL-CONSUMPTION
Authors: LAUCHLI S HEUSSER R TSCHOPP A GUTZWILLER F HORNUNG R TWISSELMANN W RUFLI T ERB P RUTTIMANN S GILLI L HIRZ W WILLI B MALINVERNI R VONOVERBECK J MATTER L DEWECK A SCHOEP M HIRSCHEL B PERRIN L DELESDERRIER JC FRANCIOLI P FREI PH CHAVE JP FLEURY F LUTHY R GROB P OPRAVIL M GABERELL H
Citation: S. Lauchli et al., SAFER SEX BEHAVIOR AND ALCOHOL-CONSUMPTION, Annals of epidemiology, 6(4), 1996, pp. 357-364
HIV VIREMIA DURING ANTITUMORAL CHEMOTHERAPY
Authors: RUTSCHMANN O PECHERE M LORENZI P KRISCHER J ROSAY A YERLY S PERRIN L SAURAT JH HIRSCHEL B
Citation: O. Rutschmann et al., HIV VIREMIA DURING ANTITUMORAL CHEMOTHERAPY, Dermatology, 193(2), 1996, pp. 173-173
IMPACT OF PHOTOTHERAPY ON HIV VIREMIA
Authors: PECHERE M LEMMONIER E SAURAT LH HIRSCHEL B PERRIN L YERLY S
Citation: M. Pechere et al., IMPACT OF PHOTOTHERAPY ON HIV VIREMIA, Dermatology, 193(2), 1996, pp. 173-173
SORPTION AND DIFFUSION OF SOLVENT VAPORS IN POLY(VINYLALCOHOL) MEMBRANES OF DIFFERENT CRYSTALLINITY DEGREES
Authors: PERRIN L NGUYEN QT CLEMENT R NEEL J
Citation: L. Perrin et al., SORPTION AND DIFFUSION OF SOLVENT VAPORS IN POLY(VINYLALCOHOL) MEMBRANES OF DIFFERENT CRYSTALLINITY DEGREES, Polymer international, 39(3), 1996, pp. 251-260
INHIBITION OF SYNCYTIA-INDUCING (SI) VIRUS BY AUTOLOGOUS SERUM FROM HIV-1-INFECTED INDIVIDUALS
Authors: GRUNOW R VONOVERBECK J FRUTIG K FREI E GERMANN D FURRER H PERRIN L PICHLER WJ
Citation: R. Grunow et al., INHIBITION OF SYNCYTIA-INDUCING (SI) VIRUS BY AUTOLOGOUS SERUM FROM HIV-1-INFECTED INDIVIDUALS, Clinical and diagnostic virology, 6(2-3), 1996, pp. 127-135
THE DROSOPHILA TEASHIRT HOMEOTIC PROTEIN IS A DNA-BINDING PROTEIN ANDMODULO, A HOM-C REGULATED MODIFIER OF VARIEGATION, IS A LIKELY CANDIDATE FOR BEING A DIRECT TARGET GENE
Authors: ALEXANDRE E GRABA Y FASANO L GALLET A PERRIN L DEZULUETA P PRADEL J KERRIDGE S JACQ B
Citation: E. Alexandre et al., THE DROSOPHILA TEASHIRT HOMEOTIC PROTEIN IS A DNA-BINDING PROTEIN ANDMODULO, A HOM-C REGULATED MODIFIER OF VARIEGATION, IS A LIKELY CANDIDATE FOR BEING A DIRECT TARGET GENE, Mechanisms of development, 59(2), 1996, pp. 191-204
RISK-FACTORS FOR TUBERCULOSIS AMONG HIV-INFECTED PATIENTS IN SWITZERLAND
Authors: SUDRE P HIRSCHEL B TOSCANI L LEDERGERBER B RIEDER HL BATTEGAY M ERB P MALINVERNI R MATTER L PICHLER WJ PERRIN L FREI P VONOVERBECK J FIERZ W VERNAZZA P LUTHY R GROB PJ FRANCIOLI P KNOPFLI D MEISTER T
Citation: P. Sudre et al., RISK-FACTORS FOR TUBERCULOSIS AMONG HIV-INFECTED PATIENTS IN SWITZERLAND, The European respiratory journal, 9(2), 1996, pp. 279-283
REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA-ENCEPHALITIS
Authors: VANDELDEN C GABRIEL V SUDRE P FLEPP M VONOVERBECK J HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: C. Vandelden et al., REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA-ENCEPHALITIS, AIDS, 10(5), 1996, pp. 509-513
ADDING SAQUINAVIR TO D4T IN ADVANCED HIV-INFECTED PATIENTS
Authors: RUTSCHMANN OT KAISER L FATHI M PERRIN L HIRSCHEL B
Citation: Ot. Rutschmann et al., ADDING SAQUINAVIR TO D4T IN ADVANCED HIV-INFECTED PATIENTS, AIDS, 10, 1996, pp. 41-41
COMBINED THERAPY WITH ZIDOVUDINE AND L-697,661 IN PRIMARY HIV-INFECTION
Authors: PERRIN L RAKIK A YERLY S BAUMBERGER C KINLOCHDELOES S PECHERE M HIRSCHEL B
Citation: L. Perrin et al., COMBINED THERAPY WITH ZIDOVUDINE AND L-697,661 IN PRIMARY HIV-INFECTION, AIDS, 10(11), 1996, pp. 1233-1237
COMBINATION THERAPY IN PRIMARY HIV-INFECTION
Authors: PERRIN L HIRSCHEL B
Citation: L. Perrin et B. Hirschel, COMBINATION THERAPY IN PRIMARY HIV-INFECTION, Antiviral research, 29(1), 1996, pp. 87-89
Risultati: 1-25 | 26-50 | 51-75 | 76-90